Immuron (IMRN) Return on Sales Growth (1y) (2017 - 2024)

Immuron (IMRN) Return on Sales Growth (1y) (2017 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 0.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Immuron 270.20 Mn 258.54 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 208.61 Bn
Dec 31, 2023 0.00
Dec 31, 2022 7.00
Dec 31, 2021 4.00 Mn
Dec 31, 2020 -4.00 Mn
Dec 31, 2019 2.00
Dec 31, 2018 0.00
Dec 31, 2017 3.00